Mustafa Khasraw

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Daniel J. McGrail, P.G. Pilié, N.U. Rashid et al. · Annals of Oncology · 2021 · 1.1K citations · Full text

Medicine, Immunology, Oncology +17

Glioma progression is shaped by genetic evolution and microenvironment interactions

Frederick S. Varn, Kevin C. Johnson, Jason T. Huse et al. · Cell · 2022 · 498 citations · Full text

Medicine, Cancer Biology, Oncology +16

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial

Antonio Omuro, Alba A. Brandes, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 485 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?

John H. Strickler, Brent A. Hanks, Mustafa Khasraw · Clinical Cancer Research · 2020 · 424 citations · Full text

Life Sciences, Immunology, Oncology +17

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

David LH Chan, Nick Pavlakis, Geoffrey Schembri et al. · Theranostics · 2017 · 286 citations · Full text

Medicine, Nuclear Medicine, Oncology +17